IQuest Enterprises has entered into a definitive agreement to acquire the active pharmaceutical ingredients (API) operations of Viatris in India. Hyderabad-based IQuest emerged as the preferred ...

Find the IQuest Co financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the IQuest Co ...

It is a moving story of a young, fidgety cat and its adventure to honor the lady love. The hero will win the love rushing into dangerous adventures opposing the hordes of mice, gangs of Don Crowleone ...

HYDERABAD: Multi-sector investment company IQuest Enterprises has entered into a definitive agreement to acquire the active pharmaceutical ingredients (API) operations of global pharmaceutical major ...

A press release from IQuest said it emerged as the preferred investor following a global competitive bid. IQuest Enterprises, a multi-sector investment company, on Monday said it has entered into a ...

The software corporation IQUEST officially announced on the 4th the launch of a service that integrates its electronic contract platform "Eolma Sign" with Newgen Solutions' enterprise resource ...

Nimagadda `Matrix' Prasad backed IQuest Enterprises to acquire Viatris API operations in India Hyderabad-based investment firm IQuest Enterprises is set to acquire the active pharmaceutical ...

IQuESt is the largest center for health systems research in the Southwest and houses over 200 faculty, post-doctoral fellows, trainees, and research staff in the Texas Medical Center. Since 2007, the ...

As of Jul 18, 2026, IQuest Co (262840) is trading at a price of 2,925 KRW, with a previous close of 2,805 KRW. The stock has fluctuated within a day range of 2,785 KRW to 2,935 KRW, while its 52-week ...